BioSpace News Archive

The CorVista ® Analysis Provides a Robust Prediction for Elevated Left Ventricular End Diastolic Pressure at the Point-Of-Care.

Sernova Corp. announced today that the first two patients in the second cohort of its active U.S. Phase 1/2 type 1 diabetes (T1D) clinical trial have been implanted with its 10-channel Cell Pouch, which provides >50% more capacity relative to the Cell Pouches used for the first cohort.

Centene Corporation announced that it has successfully completed the previously announced divestiture of its Spanish and Central European Businesses to the French private hospitals group Vivalto Santé.

Frequency Therapeutics, Inc. today announced that it will host a virtual investor event on December 13, 2022.

GE Healthcare’s Pharmaceutical Diagnostics business announced an $80 million investment to increase manufacturing capacity by 30 percent at its Active Pharmaceutical Ingredients site in Lindesnes, Norway.

Aerovate Therapeutics, Inc. today announced the publication of Phase 1 study results evaluating AV-101, a novel dry powder inhaled formulation of imatinib, in ERJ Open Research.

Calyx today announced a strategic partnership with Neosoma, Inc.

Ayala Pharmaceuticals, Inc. today is announcing a poster presentation highlighting interim results from the Phase 2 segment / Part A of the RINGSIDE Pivotal Phase 2/3 clinical trial in desmoid tumors at the Connective Tissue Oncology Society Annual Meeting.

Science 37 Holdings, Inc. and Linical Americas today announced a partnership that will facilitate the deployment of decentralized clinical trial solutions—powered by Science 37—to Linical’s international clients, enabling patient access from virtually anywhere.

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), an early-stage commercial company focused on developing meaningful innovations in immuno-dermatology, today announced that ZORYVE® (roflumilast) cream 0.3% for the treatment of plaque psoriasis in adults and adolescents is now on Express Scripts national formularies for commercial benefit plans, effective November 18.